Marta Cano, PhD is currently a postdoctoral researcher at Sant Pau Biomedical Research Institute, where she is leading the Neuroimaging & Affective Disorders Lab of the Sant Pau Mental Health Research Group, and a research fellow of the Laboratory for Neuropsychiatry & Neuromodulation at Mass General. Her research interests are primarily focused on understanding the dimensional impact of rapid-acting antidepressants on patients with treatment-resistant depression with the final aim to develop a personalized prediction model of antidepressant treatment response.